Concurrence LA and SKL. How to be further?

[Yana]

Hello!



I would like to consult to you in occasion of bad rezultata SKL and HLA.



LA-:

The wife:

LA DRB 1*11

LA DRB 1*17

The husband:

LA DRB 1*11

LA DRB 1*11



SKL:

3-rd day akt.kl.zh indexes



The wife 885 0,68

The husband 1011 1011 1,14

Pool () 4745 1989 2,25

Pool () 5472



5-th day akt.kl.zh indexes



The wife 2345 0,68

The husband 2066 0,56

Pool () 15375 4979 2,12

Pool () 16375



WHAT it is possible to do or make further? So much time is spent for searches of the reason. Now the reason is unknown, but is not clear what to do or make further to us?

Whether there is a sense to do or make the offered immunization?-so much inconsistent opinions in this occasion. What can you advise?

If to not do or make it or her, WHAT further to do or make?-so much all is already checked up.

Whether there is a sense with such analyses to go on EKO or poprobyvat next time of AI?



Thankful in advance

Yours faithfully, Yana

[YBLOKO]

At you that nevynashivanie pregnancy or difficulty with conception?

It is not enough one these results of the analysis.

Identification delaetsja both on 1 class and on 2 class HLA of system, at you one result is written only.

[Yana]

2,5 years of difficulty with conception.

Unfortunately, we have handed over only HLA an identification of II class.

[boris]

Uv. Yana!





Whether there is a sense to do or make the offered immunization?-so much inconsistent opinions in this occasion. What can you advise?

If to not do or make it or her, WHAT further to do or make?-so much all is already checked up.

Whether there is a sense with such analyses to go on EKO or poprobyvat next time of AI?



Similar questions were already in detail discussed at this forum here (http: // forums./showthread.php? t=8760) here again (http: // forums./showthread.php? t=8818).



As if to AI, I can quote the following:

*quot; Carrying out of three-four noneffective cycles of AI peerly on economic expenses of cost of carrying out of one cycle EKO, *quot;



Aboulgar M.A., Mansour R.T. et. al. Controlled ovarian hyperstimulation and intrauterine insemination for treatment of unexplained infertility should be limited to a maximum three trials. The Egyptian IVF-ET center, Cairo 11431, Egypt. Hum. Reprod., vol. 15, abst. Book 1, June 2000

Z. Philips, M. Barraza-Liorens and J. Posnett. Evaluation of the relative cost-effectiveness treatment for infertility in the UK. Human reproduction v 15, n 1, January 2000.

Gowerde A. M. et. al. Assisted reproduction: cost-effectiveness study. Lancet 2000; 355; 13-8

Zayed F; Lenton E.A.; Cooke I.D. Comparison between stimulated in-vitro fertilization and stimulated intrauterine insemination for treatment of unexplained and mild male factor. Hum. Reprod., 12 (11) : 2408-13 1997 Nov



*quot; , and the further treatment by means of AI in such situation is unpromising *quot;



Marcus Samuel F., Brinsten P.R. Interuterine insemination. In the book: R. Edwards. A textbook of In-Vitro Fertilization and Assisted Reproduction. Edited by Peter R. Brinsden. Second edition. 1999, p. 257-265.

Aboulgar M.A., Mansour R.T. et. al. Controlled ovarian hyperstimulation and intrauterine insemination for treatment of unexplained infertility should be limited to a maximum three trials. The Egyptian IVF-ET center, Cairo 11431, Egypt. Hum. Reprod., vol. 15, abst. Book 1, June 2000

Gowerde A. M. et. al. Assisted reproduction: cost-effectiveness study. Lancet 2000; 355; 13-8